MannKind
フィルター:
MannKind
Company
Topic
Show
2022
10 Nov 2022
MannKind
MannKind is a US-based biopharmaceutical company which has developed the only FDA-cleared inhaled insulin device currently available on the market. On 9 November 2022, the company presented its inhaled insulin device at the 2022 Diabetes Technology Meeting (DTM).
Included are:
1 Apr 2022
Diabetes Management Technologies 2022-2032: Markets, Players, and Forecasts
IDTechEx Report:
